Machine Learning-Assisted Ensemble Analysis for the Prediction of Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer

被引:2
|
作者
Huang, Yibao [1 ]
Zhu, Qingqing [1 ]
Xue, Liru [1 ]
Zhu, Xiaoran [1 ]
Chen, Yingying [1 ]
Wu, Mingfu [1 ]
机构
[1] Huazhong Univ Sci & Technol, Natl Clin Res Ctr Obstetr & Gynecol Dis, Key Lab Canc Invas & Metastasis, Tongji Hosp,Tongji Med Coll,Dept Gynecol,Minist E, Wuhan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
locally advanced cervical cancer; neoadjuvant chemotherapy; machine learning analysis; predictive model; pathology response; INFLAMMATION MARKERS; RADICAL HYSTERECTOMY; CURATIVE RESECTION; SURGERY; VALIDATION; FIBRINOGEN; EFFICACY;
D O I
10.3389/fonc.2022.817250
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The clinical benefit of neoadjuvant chemotherapy (NACT) before concurrent chemoradiotherapy (CCRT) vs. adjuvant chemotherapy after CCRT is debated. Non-response to platinum-based NACT is a major contributor to poor prognosis, but there is currently no reliable method for predicting the response to NACT (rNACT) in patients with locally advanced cervical cancer (LACC). In this study we developed a machine learning (ML)-assisted model to accurately predict rNACT. We retrospectively analyzed data on 636 patients diagnosed with stage IB2 to IIA2 cervical cancer at our hospital between January 1, 2010 and December 1, 2020. Five ML-assisted models were developed from candidate clinical features using 2-step estimation methods. Receiver operating characteristic curve (ROC), clinical impact curve, and decision curve analyses were performed to evaluate the robustness and clinical applicability of each model. A total of 30 candidate variables were ultimately included in the rNACT prediction model. The areas under the ROC curve of models constructed using the random forest classifier (RFC), support vector machine, eXtreme gradient boosting, artificial neural network, and decision tree ranged from 0.682 to 0.847. The RFC model had the highest predictive accuracy, which was achieved by incorporating inflammatory factors such as platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, neutrophil-to-albumin ratio, and lymphocyte-to-monocyte ratio. These results demonstrate that the ML-based prediction model developed using the RFC can be used to identify LACC patients who are likely to respond to rNACT, which can guide treatment selection and improve clinical outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Machine learning applied to MRI evaluation for the detection of lymph node metastasis in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy
    Francesca Arezzo
    Gennaro Cormio
    Michele Mongelli
    Gerardo Cazzato
    Erica Silvestris
    Anila Kardhashi
    Ambrogio Cazzolla
    Claudio Lombardi
    Vincenzo Venerito
    Vera Loizzi
    [J]. Archives of Gynecology and Obstetrics, 2023, 307 : 1911 - 1919
  • [42] Machine learning applied to MRI evaluation for the detection of lymph node metastasis in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy
    Arezzo, Francesca
    Cormio, Gennaro
    Mongelli, Michele
    Cazzato, Gerardo
    Silvestris, Erica
    Kardhashi, Anila
    Cazzolla, Ambrogio
    Lombardi, Claudio
    Venerito, Vincenzo
    Loizzi, Vera
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2023, 307 (06) : 1911 - 1919
  • [43] FDG-PET FOR EVALUATING RESPONSE TO NEOADJUVANT CHEMOTHERAPY (NACT) IN LOCALLY ADVANCED CERVICAL CANCER (LACC)
    Scaffa, C.
    Caraco, C.
    Losito, N. S.
    Pisano, C.
    Scala, F.
    Lastoria, S.
    Greggi, S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [44] PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer
    Shimomura, Masahiro
    Fukuda, Takeshi
    Awazu, Yuichiro
    Nanno, Shigenori
    Inoue, Yuta
    Matsubara, Hiroaki
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    [J]. ONCOLOGY LETTERS, 2021, 21 (02)
  • [45] NUCLEAR MORPHOMETRY AS A PREDICTOR OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY PLUS RADIOTHERAPY IN LOCALLY ADVANCED CERVICAL-CANCER
    YACOUB, SF
    SHAEFFER, J
    ELMAHDI, AM
    FARIS, L
    ZHU, A
    [J]. GYNECOLOGIC ONCOLOGY, 1994, 54 (03) : 327 - 332
  • [46] NEOADJUVANT CHEMOTHERAPY AND RADICAL SURGERY IN LOCALLY ADVANCED CERVICAL-CANCER - PROGNOSTIC FACTORS FOR RESPONSE AND SURVIVAL
    PANICI, PB
    SCAMBIA, G
    BAIOCCHI, G
    GREGGI, S
    RAGUSA, G
    GALLO, A
    CONTE, M
    BATTAGLIA, F
    LAURELLI, G
    RABITTI, C
    CAPELLI, A
    MANCUSO, S
    [J]. CANCER, 1991, 67 (02) : 372 - 379
  • [47] A Machine Learning Model for Predicting a Major Response to Neoadjuvant Chemotherapy in Advanced Gastric Cancer
    Chen, Yonghe
    Wei, Kaikai
    Liu, Dan
    Xiang, Jun
    Wang, Gang
    Meng, Xiaochun
    Peng, Junsheng
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [48] Deep learning nomogram for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer patients
    Zhang, Jingjing
    Zhang, Qiang
    Zhao, Bo
    Shi, Gaofeng
    [J]. ABDOMINAL RADIOLOGY, 2024,
  • [49] Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
    Sugiyama, T
    Nishida, T
    Kumagai, S
    Nishio, S
    Fujiyoshi, K
    Okura, N
    Yakushiji, M
    Hiura, M
    Umesaki, N
    [J]. BRITISH JOURNAL OF CANCER, 1999, 81 (01) : 95 - 98
  • [50] Neoadjuvant chemotherapy in locally advanced cervical cancer in pregnancy-Review of the literature
    Mandic, Aljosa
    Maricic, Slobodan
    Malenkovic, Goran
    Stojic, Ivana
    Gutic, Bojana
    [J]. JOURNAL OF BUON, 2020, 25 (02): : 597 - 604